EOD Regional Nodes

This input is used for staging

Notes

**Note 1:** **Regional nodes and nodes, NOS** * Code only regional nodes and nodes, NOS in this field. Distant nodes are coded in EOD Mets. **Note 2:** **Mesenteric nodes** * The specific location of the mesenteric nodes determines whether they are regional or distant. * If the specific location is not described, code in EOD Regional Nodes. **Note 3:** **Porta hepatic nodes** * Porta hepatic nodes are recorded as distant for Body and Tail and should be coded in EOD Mets. * If the specific location for hepatic nodes is not described, code in EOD Regional Nodes. **Note 4:** **CLINICAL AND PATHOLOGICAL codes** * This schema has lymph node codes that are defined as **CLINICAL** assessment only or **PATHOLOGICAL** assessment only. * **PATHOLOGICAL** assessment only codes (300, 700) are used when * Any microscopic examination of regional lymph nodes, includes * FNA, core biopsy, sentinel node biopsy or lymph node excision done during the clinical work up **AND/OR** * Lymph node dissection performed * Pathological codes 300, 700 take priority over codes 725, 775, 800 * **CLINICAL** assessment only codes (725, 775) are used when the **only** information on nodal involvement is based on **physical exam or imaging** * These codes are specifically for when there is no **microscopic confirmation** of regional lymph nodes (*Regional Nodes Positive = 98, 99*) * **Note:** Use code 300 if *Regional Nodes Positive is 01-90, 95* * Remaining codes (no designation of **CLINICAL** or **PATHOLOGICAL** only assessment) can be used based on clinical and/or pathological information * **Code 000** is used when there is no evidence of regional lymph nodes clinically **OR** lymph nodes are negative pathologically (*Regional Nodes Positive = 00, 98*) * **Code 800** is used when there are positive nodes (clinical or pathological), but the specific lymph nodes or number of positive nodes is unknown (*Regional Nodes Positive = 97*) * **Code 999** is used when the lymph node status is unknown and *Regional Nodes Positive = 99*

Default

999

NAACCR Item

NAACCR #774
Code Description SS2018 N
000 No regional lymph node involvement NONE
300 **PATHOLOGICAL ASSESSMENT ONLY** All sites - Anterior, NOS - Common hepatic artery - Hepatic, NOS - Inferior to head and body of pancreas - Lateral aortic (lumbar) - Pancreaticoduodenal (anterior, posterior) - Peripancreatic, NOS - Posterior, NOS - Proximal mesenteric (anterior, posterior) - Retroperitoneal - Superior mesenteric - Superior to head and body of pancreas Pancreas Head (C250) - Common bile duct (pericholedochal) - Lateral wall (right) - Portal vein - Pyloric (infrapyloric, retropyloric, subpyloric, suprapyloric, NOS) Pancreas Body and Tail (C251-C252) - Gastroepiploic (gastro-omental, left) - Pancreaticosplenic (pancreaticolienal) - Splenic (artery, hilum, lineal) - Suprapancreatic Pancreas Other (C253-C254, C257-C259) - Celiac - Common bile duct (pericholedochal) - Gastroepiploic (gastro-omental) - Lateral wall right - Pancreaticosplenic (pancreaticolienal) - Portal vein - Pyloric (infrapyloric, retropyloric, subpyloric, suprapyloric, NOS) - Splenic (artery, hilum, lineal) - Suprapancreatic RN
700 **PATHOLOGICAL ASSESSMENT ONLY** Pancreas Body Tail (C251, C252) (see code 300 for Pancreas Other, or EOD Mets for Pancreas Head) - Celiac D
725 **CLINICAL ASSESSMENT ONLY** One-three positive nodes clinically OR stated as Clinical N1 RN
775 **CLINICAL ASSESSMENT ONLY** Four or more positive nodes clinically OR stated as Clinical N2 RN
800 **Unknown if clinical or pathological assessment** * Unknown how many positive nodes Regional lymph node(s), NOS Lymph node(s), NOS RN
999 Unknown; regional lymph node(s) not stated Regional lymph node(s) cannot be assessed Not documented in medical record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Kakar, S., Pawlik, T.M., Vauthey, J.N., et al. **Exocrine Pancreas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cacer Staging Manual. 8th Ed. New York: Springer; 2017